Find Jobs
Find Jobs Near You – Available Work in Your Location
Skip to job details
We are seeking a highly motivated senior scientist with strong expertise in human immunology, immune profiling, and disease-relevant multicellular assay systems, combined with working knowledge of xRNA biotherapeutics and general immunogenicity principles. The successful candidate will lead immunology-focused studies to evaluate how novel biotherapeutic modalities, including antibody-oligonucleotide conjugates (AOCs) and related xRNA approaches, interact with immune cells and pathways. This role will generate mechanistic insights to inform therapeutic design, candidate selection, translational biomarker strategies, and early safety risk assessment, with a primary emphasis on immunological understanding and assay excellence.
NA
Novartis AG
Senior Scientist Immunology and biotherapeutics
Career Insights for Assay Development Scientist
See where this job fits in the broader career landscape. Knowing your career path helps you see what's possible from here.
Scorecard
Based on Massachusetts data
Review key factors to help you decide if this role fits your goals. How is this calculated?
What they do
An Assay Development Scientist creates assays or systems to test and evaluate the effect of a chemical compound on an organism. Directs assay development as part of a research process to develop new drugs.
$115,313 / year median in Massachusetts
+10% projected growth
Job Description
WORK ARRANGEMENT
On-Site Working, #On-siteLOCATION
Cambridge, MARELOCATION SUPPORT:
This role is based in Cambridge, United States. Novartis is unable to offer relocation support: please only apply if accessible.We are seeking a highly motivated senior scientist with strong expertise in human immunology, immune profiling, and disease-relevant multicellular assay systems, combined with working knowledge of xRNA biotherapeutics and general immunogenicity principles. The successful candidate will lead immunology-focused studies to evaluate how novel biotherapeutic modalities, including antibody-oligonucleotide conjugates (AOCs) and related xRNA approaches, interact with immune cells and pathways. This role will generate mechanistic insights to inform therapeutic design, candidate selection, translational biomarker strategies, and early safety risk assessment, with a primary emphasis on immunological understanding and assay excellence.